Management of HIV/AIDS – Current Practice & Future Hopes
Keywords:
HIV, AIDS, ART, RNA Virus, CD4Abstract
HIV/ AIDS pandemic, that started in the late twentieth century has continued into the 21st century despite all the research and effort to control it. It is estimated that more than 34.3 million people worldwide are infected with HIV and 18.6 million deaths have occurred. By 2020 about 20 million will be orphaned due to the virus. India has the highest number of people with HIV globally, second only to South Africa. There are approximately 16,000 new infections every day. The advent of ART revolutionized the lives of people living with HIV/ AIDS but ART is not a cure; ART merely keeps the viral replication suppressed. When ART is stopped the virus rebounds within a few weeks in almost all infected individuals. Recently UNAIDS has recommended the new strategy for control of HIV infection (Test & Treat) and laid down new targets (90-90-90 by 2020). This article reviews the current practices in management of HIV/ AIDS and highlights the future diagnostic therapeutic and preventive modalities that may soon become available to the clinicians.
Downloads
References
Mark Heywood. Lancet Vol 3869989 July 2015.
Dr. Thomas A. Rasmussen Prof. Sharon R Lewin. Spotlight No. 15- July 2016 pgs. 103-104mark Heywood.Lencet vol 38699989,July 2015171-218
Branson BM, Handsfeild H, Lampe MO et al, Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health care settings. MMWR Recomm. Rep.2006 Sept 22,55:1-17
Marcus Low & Kristanna Peris: Spotlight Science#15-July 2016 pgs 108-111
Kumaraswamy APN, Sanjay Pujari, Antiretroviral therapy in the Indian setting: When and what start, when and what to switch to? Indian journal of Medical Research. 2011: 1(134)787-800
NACO. Antiretroviral therapy guidelines for HIV infected Adults and Adolescents in India. NACO 2015. (updated Sept. 2013-12 June 2016
Guidelines on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV, WHO AIDS technical Bulletin. 20015,78.
Rerks-Ngarm S, Pilisuttithum P, Nitayaphan S, Kaewungwal J, Chiu J, Paris P, et al. Vaccination with ALVAS and AIDSVAX to prevent HIV-1 infection in Thailand. New England Journal of Medicine. 2009; 361(23):2209-2C
Karuna ST, Mulligan MJ, Grove D et al Efficacy of a DNA/r Ad5 HIV-1 preventable vaccine. New England journal of Medicine. 2013; 369(22): 2083-92.
Cromwell Ta, Hatano H. Clinical outcomes and antiretroviral therapy in "elite" controllers: a review of literature. J. Virus Erad. 2015;1(2): 72-77
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.